Heath, S., Jiyu, J., Bansal, A., Sabbaj, S., Shacka, J., & Goepfert, P. (2009). P16-25. HIV specific CTL from elite controllers have a unique survival advantage. BioMed Central.
シカゴスタイル引用形Heath, SL, J. Jiyu, A. Bansal, S. Sabbaj, JJ Shacka, , PA Goepfert. P16-25. HIV Specific CTL From Elite Controllers Have a Unique Survival Advantage. BioMed Central, 2009.
MLA引用形式Heath, SL, et al. P16-25. HIV Specific CTL From Elite Controllers Have a Unique Survival Advantage. BioMed Central, 2009.
警告: この引用は必ずしも正確ではありません.